0,918  0,004  Amyloid beta aggregation inhibitor
0,885  0,007  Apoptosis agonist
0,827  0,004  Antioxidant
0,797  0,004  Free radical scavenger
0,783  0,002  Estrogen receptor alpha antagonist
0,785  0,005  Antiosteoporotic
0,782  0,011  Antineoplastic (breast cancer)
0,771  0,002  NOS3 expression enhancer
0,786  0,020  Alpha-glucosidase inhibitor
0,747  0,005  Bone diseases treatment
0,743  0,009  Alzheimer's disease treatment
0,742  0,014  Antineoplastic (lung cancer)
0,729  0,004  Antimutagenic
0,724  0,004  Antiamyloidogenic
0,715  0,005  Lipoxygenase inhibitor
0,715  0,009  Chemopreventive
0,706  0,006  NOS2 expression inhibitor
0,686  0,006  Nitric oxide antagonist
0,684  0,011  Prostate cancer treatment
0,676  0,004  Skin whitener
0,672  0,002  Cystathionine beta-synthase inhibitor
0,678  0,023  Transcription factor NF kappa B inhibitor
0,658  0,003  Estrogen antagonist
0,628  0,004  Topoisomerase II inhibitor
0,622  0,003  Estrogen receptor beta antagonist
0,620  0,008  UGT1A6 substrate
0,619  0,011  UGT1A9 substrate
0,598  0,009  CYP2C19 inhibitor
0,595  0,008  CYP1A2 inhibitor
0,590  0,004  Lipid peroxidase inhibitor
0,579  0,005  Antihypertriglyceridemic
0,595  0,024  Antineoplastic (colorectal cancer)
0,581  0,015  CTGF expression inhibitor
0,570  0,012  Caspase 3 stimulant
0,581  0,024  Antineoplastic (colon cancer)
0,551  0,003  Estrogen agonist
0,563  0,016  Antineoplastic (cervical cancer)
0,596  0,055  Antiinflammatory
0,539  0,002  Estrogen receptor beta agonist
0,538  0,006  Monophenol monooxygenase inhibitor
0,555  0,026  Antiparkinsonian
0,523  0,003  LDLR expression enhancer
0,550  0,031  Antileukemic
0,531  0,017  AR expression inhibitor
0,514  0,008  P-glycoprotein inhibitor
0,511  0,019  NOS3 expression inhibitor
0,494  0,006  Amylase inhibitor
0,502  0,026  Antihypercholesterolemic
0,499  0,024  Antineoplastic (melanoma)
0,494  0,019  Antineoplastic (glioma)
0,475  0,005  UGT2B15 substrate
0,474  0,004  SULT1A3 substrate
0,503  0,040  Antibacterial
0,506  0,045  TNF expression inhibitor
0,508  0,048  Cyclophilin D inhibitor
0,508  0,048  Antidiabetic
0,493  0,042  15-Lipoxygenase inhibitor
0,502  0,059  Caspase 9 stimulant
0,468  0,028  Antifungal
0,450  0,009  Melanin inhibitor
0,464  0,026  Chemoprotective
0,448  0,016  Vasodilator
0,456  0,026  Apoptosis antagonist
0,437  0,010  UGT1A3 substrate
0,429  0,007  Sulfotransferase substrate
0,448  0,030  Cardioprotectant
0,440  0,022  UGT2B4 substrate
0,413  0,006  Acetylcholinesterase inhibitor
0,426  0,020  Antimitotic
0,411  0,005  Topoisomerase I inhibitor
0,413  0,016  UGT1A1 substrate
0,414  0,019  Vascular (periferal) disease treatment
0,403  0,010  Genotoxic
0,412  0,019  UDP-glucuronosyltransferase substrate
0,429  0,053  Immunosuppressant
0,411  0,036  ICAM1 expression inhibitor
0,401  0,028  Antineoplastic (glioblastoma multiforme)
0,391  0,030  Proliferative diseases treatment
0,389  0,031  DNA damaging
0,354  0,005  Xanthine oxidase inhibitor
0,402  0,053  Angiogenesis inhibitor
0,377  0,032  Hypoglycemic
0,352  0,014  Tubulin antagonist
0,348  0,013  Cholinergic
0,335  0,004  Postmenopausal disorders treatment
0,359  0,039  Antiprotozoal (Leishmania)
0,328  0,019  VCAM1 expression inhibitor
0,332  0,022  Hepatoprotectant
0,370  0,063  Antiprotozoal (Plasmodium)
0,357  0,050  Antineoplastic (brain cancer)
0,346  0,048  Antituberculosic
0,314  0,019  Antineoplastic (squamous cell carcinoma)
0,337  0,045  Antineoplastic (osteosarcoma)
0,345  0,058  Antimycobacterial
0,335  0,055  CYP1A2 substrate
0,328  0,049  Antineoplastic (non-small cell lung cancer)
0,362  0,085  Antiprotozoal
0,334  0,062  Antineoplastic (ovarian cancer)
0,325  0,060  Lipoprotein disorders treatment
0,346  0,083  CYP2C9 inhibitor
0,275  0,013  Protein-tyrosine phosphatase 1B inhibitor
0,283  0,022  Protein-tyrosine phosphatase inhibitor
0,308  0,050  Cytostatic
0,268  0,011  Antihemorrhagic
0,305  0,049  Antineoplastic (liver cancer)
0,261  0,009  Topoisomerase II alpha inhibitor
0,305  0,055  Antipyretic
0,321  0,071  Hepatic disorders treatment
0,253  0,004  Estrogen receptor alpha agonist
0,299  0,052  Antineoplastic (renal cancer)
0,298  0,052  Cytotoxic
0,260  0,015  Histone deacetylase SIRT1 inhibitor
0,260  0,018  Glutathione S-transferase substrate
0,299  0,066  Antineoplastic (multiple myeloma)
0,256  0,030  Contraceptive
0,293  0,069  Hypoxia-inducible factor 1 alpha inhibitor
0,276  0,061  Sensitization
0,296  0,084  Antineoplastic (small cell lung cancer)
0,289  0,081  Antiischemic
0,222  0,014  SULT1A1 substrate
0,247  0,043  UGT2B7 substrate
0,218  0,014  Histone deacetylase class III inhibitor
0,242  0,039  Insulin sensitizer
0,204  0,006  SULT1E1 substrate
0,242  0,043  Neurotrophic factor enhancer
0,218  0,021  Gout treatment
0,227  0,033  MAO inhibitor
0,216  0,023  Cholesterol synthesis inhibitor
0,204  0,012  Beta glucuronidase inhibitor
0,268  0,076  Huntington's disease treatment
0,265  0,079  GST M1-1 substrate
0,193  0,017  UGT2B1 substrate
0,205  0,032  Cyclooxygenase 1 inhibitor
0,192  0,019  Beta amyloid protein antagonist
0,199  0,028  Neurotrophic factor
0,260  0,090  Antihypoxic
0,295  0,126  Histamine release inhibitor
0,176  0,009  Aldose reductase inhibitor
0,265  0,098  CYP2D6 substrate
0,290  0,128  Antipruritic, allergic
0,235  0,075  Hypolipemic
0,216  0,060  Pneumotoxic
0,229  0,073  Antihypotensive
0,173  0,019  Antineoplastic (uterine cancer)
0,240  0,091  5 Hydroxytryptamine uptake stimulant
0,224  0,078  Antineoplastic (lymphoma)
0,174  0,030  MAO B inhibitor
0,206  0,066  Mutagenic
0,210  0,073  Nitric-oxide synthase stimulant
0,194  0,058  Prostatic (benign) hyperplasia treatment
0,237  0,101  CYP2C19 substrate
0,185  0,050  Antineoplastic (carcinoma)
0,220  0,086  Antineoplastic (lymphocytic leukemia)
0,155  0,022  Creatine kinase inhibitor
0,144  0,010  Histone deacetylase SIRT1 stimulant
0,144  0,010  Histone deacetylase stimulant
0,151  0,018  NAD(P)H dehydrogenase (quinone) inhibitor
0,139  0,008  Elastase 1 inhibitor
0,224  0,093  Aldehyde oxidase inhibitor
0,142  0,010  Alpha tubulin antagonist
0,164  0,033  5-Lipoxygenase inhibitor
0,145  0,015  Keratolytic
0,154  0,023  Multidrug resistance-associated protein 1 inhibitor
0,156  0,028  Carbonic anhydrase XV inhibitor
0,193  0,066  Myocardial ischemia treatment
0,155  0,029  Papain-like protease (SARS coronavirus) inhibitor
0,152  0,028  Carbonic anhydrase III inhibitor
0,173  0,051  Antidiarrheal
0,158  0,039  MAO A inhibitor
0,135  0,017  Dopamine D1 antagonist
0,160  0,044  DNA polymerase I inhibitor
0,132  0,016  HIV-1 integrase (3'-Processing) inhibitor
0,126  0,011  SULT1A2 substrate
0,160  0,048  M18 aspartyl aminopeptidase inhibitor
0,148  0,036  Endometrios treatment
0,141  0,030  Dementia treatment
0,135  0,029  Vascular dementia treatment
0,165  0,063  UGT2B9 substrate
0,121  0,025  Ornithine decarboxylase inhibitor
0,115  0,020  Lipase inhibitor
0,111  0,019  Beta tubulin antagonist
0,245  0,154  CYP2C9 substrate
0,156  0,065  Cyclooxygenase inhibitor
0,149  0,060  Antifungal (Cryptococcus)
0,140  0,052  Alkylator
0,118  0,030  Carbonic anhydrase VI inhibitor
0,110  0,023  Dopamine agonist
0,124  0,037  Breast cancer-resistant protein inhibitor
0,192  0,107  Platelet antagonist
0,152  0,067  Protein kinase stimulant
0,120  0,034  UGT2B11 substrate
0,207  0,122  Antineoplastic (pancreatic cancer)
0,163  0,078  UGT1A4 substrate
0,232  0,149  CYP3A4 substrate
0,168  0,085  Diabetic nephropathy treatment
0,154  0,073  Interferon gamma antagonist
0,102  0,022  HIV-1 integrase (Strand Transfer) inhibitor
0,173  0,095  CYP2B6 inhibitor
0,156  0,081  Antiviral (Hepatitis C)
0,176  0,102  VEGF expression inhibitor
0,083  0,012  Postcoital contraceptive
0,113  0,043  Prolactin inhibitor
0,187  0,120  Tumour necrosis factor alpha release inhibitor
0,110  0,044  Uric acid excretion stimulant
0,078  0,016  Heme oxygenase stimulant
0,079  0,018  Transcription factor RelA inhibitor
0,206  0,147  Metabolic disease treatment
0,194  0,136  Antineoplastic (sarcoma)
0,221  0,163  Vasodilator, coronary
0,111  0,053  Toll-Like receptor 4 antagonist
0,071  0,013  Squalene epoxidase inhibitor
0,101  0,048  ABCA1 expression enhancer
0,112  0,059  Electron transport complex I inhibitor
0,157  0,105  Antiviral (Hepatitis)
0,056  0,005  Estrogen-related receptor beta antagonist
0,120  0,070  Contraceptive female
0,077  0,026  Xanthine dehydrogenase inhibitor
0,150  0,099  Carcinogenic
0,097  0,047  Antineoplastic antibiotic
0,078  0,028  Aromatase inhibitor
0,158  0,108  Antirickettsial
0,150  0,101  Amyloid beta precursor protein antagonist
0,052  0,005  CYP24 inhibitor
0,123  0,076  Cyclooxygenase 2 inhibitor
0,121  0,075  Gastritis treatment
0,064  0,018  Estradiol 17 beta-dehydrogenase inhibitor
0,065  0,019  Glucose-6-phosphate translocase inhibitor
0,090  0,045  Antiprotozoal activity enhancer
0,102  0,060  Anabolic
0,106  0,064  DOPA decarboxylase inhibitor
0,055  0,014  Dopamine D5 agonist
0,042  0,005  Dopamine D1 agonist
0,105  0,068  DNA intercalator
0,092  0,055  Antiviral (Hepatitis A)
0,071  0,034  Adrenaline uptake inhibitor
0,110  0,074  Microtubule formation inhibitor
0,067  0,033  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,043  0,011  HMG CoA reductase inhibitor
0,136  0,104  Antihelmintic (Nematodes)
0,084  0,052  Opioid kappa receptor antagonist
0,088  0,058  Opioid antagonist
0,079  0,051  Na+ K+ transporting ATPase inhibitor
0,127  0,101  Antiviral (Herpes)
0,073  0,048  Histidine decarboxylase inhibitor
0,042  0,020  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,065  0,045  Leukotriene antagonist
0,031  0,013  Sodium/glucose cotransporter 2 inhibitor
0,081  0,064  Alpha 2 adrenoreceptor antagonist
0,050  0,033  Topoisomerase II beta inhibitor
0,131  0,115  Prostate disorders treatment
0,028  0,013  Sodium/glucose cotransporter inhibitor
0,034  0,021  Glucocorticoid antagonist
0,055  0,042  Leukotriene C antagonist
0,097  0,085  Antifungal (Aspergillus)
0,137  0,127  Pyruvate kinase inhibitor
0,104  0,097  Cyclooxygenase 3 inhibitor
0,056  0,049  Neuraminidase inhibitor
0,038  0,030  Retinoic acid alpha receptor agonist
0,204  0,197  Ulceration
0,040  0,033  Dopamine D5 antagonist
0,016  0,010  Calcium-sensing receptor antagonist
0,139  0,135  Antineoplastic (bone cancer)
0,076  0,073  Ca(v)3.1 blocker
0,066  0,063  Alpha 2a adrenoreceptor antagonist
0,076  0,073  Thioredoxin reductase inhibitor
0,123  0,122  Antipruritic, non-allergic
0,029  0,027  Estrogen-related receptor alpha antagonist

